Embed Size (px)
Citation preview
Figure 6: Risks of outcomes in the primary (A) and secondary (B) prevention cohorts for men in various BMI groups compared to patients in the “normal BMI” group. The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale.
‘’ ‘’ ‘’ ‘’
‘’ ‘’ ‘’ ‘’
‘’ ‘’ ‘’ ‘’
Supplementary data files
AHazard Ratios
95% CI
Figure 6: Risks of outcomes in the primary (A) and secondary (B) prevention cohorts for men in various BMI groups compared to patients in the “normal BMI” group. The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale.
‘’ ‘’ ‘’ ‘’
‘’ ‘’ ‘’ ‘’
‘’ ‘’ ‘’ ‘’
Supplementary data files
BHazard Ratios
95% CI
Figure 7: Risks of outcomes in the primary (A) and secondary (B) prevention cohorts for women in various BMI groups compared to patients in the “normal BMI” group. The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale.
‘’ ‘’ ‘’ ‘’
‘’ ‘’ ‘’ ‘’
‘’ ‘’ ‘’ ‘’
Supplementary data files
AHazard Ratios
95% CI
Figure 7: Risks of outcomes in the primary (C) and secondary (B) prevention cohorts for women in various BMI groups compared to patients in the “normal BMI” group. The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale.
‘’ ‘’ ‘’ ‘’
‘’ ‘’ ‘’ ‘’
‘’ ‘’ ‘’ ‘’
Supplementary data files
BHazard Ratios
95% CI
Figure 8: Risks of outcomes in the secondary prevention cohort for patients in five quintiles (Q) of waist circumference (WC) compared to patients in the 2nd quintile of WC. The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale.
Supplementary data files
‘’ ‘’ ‘’
‘’ ‘’ ‘’
Hazard Ratios 95% CI
‘’ ‘’ ‘’
Figure 9: Risks of outcomes in the secondary prevention cohort for patients with optimal therapy (A) and suboptimal therapy (B) in five quintiles (Q) of waist circumference (WC) compared to patients in the reference group (quintile 2). The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale.
A
Supplementary data files
Hazard Ratios 95% CI
‘’ ‘’ ‘’
‘’ ‘’ ‘’
‘’ ‘’ ‘’
Figure 9: Risks of outcomes in the secondary prevention cohort for patients with optimal therapy (A) and suboptimal therapy (B) in five quintiles (Q) of waist circumference (WC) compared to patients in the reference group (quintile 2). The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale.
B
Supplementary data files
‘’ ‘’ ‘’
‘’ ‘’ ‘’
‘’ ‘’ ‘’
Hazard Ratios 95% CI
Figure 10: Risks of outcomes in the secondary prevention cohort for men with optimal therapy (A) and suboptimal therapy (B) in various BMI groups compared to patients in the reference group (18 kg/m²<BMI<25 kg/m²). The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale.
‘’ ‘’ ‘’ ‘’
‘’ ‘’ ‘’ ‘’
‘’ ‘’ ‘’ ‘’
Supplementary data files
AHazard Ratios
95% CI
Figure 10: Risks of outcomes in the secondary prevention cohort for men with optimal therapy (A) and suboptimal therapy (B) in various BMI groups compared to patients in the reference group (18 kg/m²<BMI<25 kg/m²). The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale.
‘’ ‘’ ‘’ ‘’
‘’ ‘’ ‘’ ‘’
‘’ ‘’ ‘’ ‘’
Supplementary data files
BHazard Ratios 95% CI
Figure 11: Risks of outcomes in the secondary prevention cohort for women with optimal therapy (A) and suboptimal therapy (B) in various BMI groups compared to patients in the reference group (18 kg/m²<BMI<25 kg/m²). The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale.
‘’ ‘’ ‘’ ‘’
‘’ ‘’ ‘’ ‘’
‘’ ‘’ ‘’ ‘’
Supplementary data files
AHazard Ratios
95% CI
Figure 11: Risks of outcomes in the secondary prevention cohort for women with optimal therapy (A) and suboptimal therapy (B) in various BMI groups compared to patients in the reference group (18 kg/m²<BMI<25 kg/m²). The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale.
‘’ ‘’ ‘’ ‘’
‘’ ‘’ ‘’ ‘’
‘’ ‘’ ‘’ ‘’
Supplementarry data files
B
Favor other BMI Favor BMI 18-25
Hazard Ratios 95% CI
